These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 37397157)

  • 1. Efficacy and safety of subcutaneous immunotherapy in asthmatic children allergic to house dust mite: a meta-analysis and systematic review.
    Zheng C; Xu H; Huang S; Chen Z
    Front Pediatr; 2023; 11():1137478. PubMed ID: 37397157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy comparison and safety analysis of subcutaneous specific immunotherapy with standardized house dust mite allergen in patients with single and multiple allergic rhinitis].
    Huang HH; Xu C; Liu L; Chai RN
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jun; 56(6):774-783. PubMed ID: 35785859
    [No Abstract]   [Full Text] [Related]  

  • 3. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of subcutaneous immunotherapy in mite-sensitized subjects with asthma: a meta-analysis.
    Lu Y; Xu L; Xia M; Li Y; Cao L
    Respir Care; 2015 Feb; 60(2):269-78. PubMed ID: 25389355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergen immunotherapy for allergic asthma: A systematic review and meta-analysis.
    Dhami S; Kakourou A; Asamoah F; Agache I; Lau S; Jutel M; Muraro A; Roberts G; Akdis CA; Bonini M; Cavkaytar O; Flood B; Gajdanowicz P; Izuhara K; Kalayci Ö; Mosges R; Palomares O; Pfaar O; Smolinska S; Sokolowska M; Asaria M; Netuveli G; Zaman H; Akhlaq A; Sheikh A
    Allergy; 2017 Dec; 72(12):1825-1848. PubMed ID: 28543086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Allergen-specific immune therapy in the treatment of asthma].
    Malling HJ
    Ugeskr Laeger; 2000 Jan; 162(4):477-9. PubMed ID: 10697443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-cervical lymphatic immunotherapy for dust mite-induced allergic rhinoconjunctivitis in children: a 3-year prospective randomized controlled trial.
    Wang Q; Wang K; Qin Y; Huang W; Li Y; Yu Q; Xiong Y; Guo Y; Zheng R; Tang J
    Front Immunol; 2023; 14():1144813. PubMed ID: 37593733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual immunotherapy for asthma.
    Fortescue R; Kew KM; Leung MST
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD011293. PubMed ID: 32926419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. House Dust Mite Sublingual Immunotherapy for Pediatric Patients With Allergic Asthma.
    Richards JR; Stumpf JL
    Ann Pharmacother; 2018 Oct; 52(10):1019-1030. PubMed ID: 29642713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of house dust mite subcutaneous immunotherapy in polysensitized children with allergic asthma.
    Zhang P; Jia Y; Jing Z; Huang J; Wu H; Sun X
    Pulm Pharmacol Ther; 2023 Feb; 78():102187. PubMed ID: 36603742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Effect of Sublingual and Subcutaneous Immunotherapy in Dust Mite-Allergic Children With Asthma/Rhinitis: A 3-Year Prospective Randomized Controlled Trial.
    Karakoc-Aydiner E; Eifan AO; Baris S; Gunay E; Akturk E; Akkoc T; Bahceciler NN; Barlan IB
    J Investig Allergol Clin Immunol; 2015; 25(5):334-42. PubMed ID: 26727762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term efficacy of house dust mite subcutaneous immunotherapy in allergic rhinitis patients].
    Lou HF; Huang YR; Wang CS; Wang XD; Zhao Y; Cao FF; Zhang L
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Nov; 32(21):1627-1631. PubMed ID: 30400685
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial.
    Eifan AO; Akkoc T; Yildiz A; Keles S; Ozdemir C; Bahceciler NN; Barlan IB
    Clin Exp Allergy; 2010 Jun; 40(6):922-32. PubMed ID: 20100188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial.
    Virchow JC; Backer V; Kuna P; Prieto L; Nolte H; Villesen HH; Ljørring C; Riis B; de Blay F
    JAMA; 2016 Apr; 315(16):1715-25. PubMed ID: 27115376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous Versus Sublingual Immunotherapy for Adults with Allergic Rhinitis: A Systematic Review with Meta-Analyses.
    Tie K; Miller C; Zanation AM; Ebert CS
    Laryngoscope; 2022 Mar; 132(3):499-508. PubMed ID: 33929726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergen immunotherapy for atopic dermatitis: Systematic review and meta-analysis of benefits and harms.
    Yepes-Nuñez JJ; Guyatt GH; Gómez-Escobar LG; Pérez-Herrera LC; Chu AWL; Ceccaci R; Acosta-Madiedo AS; Wen A; Moreno-López S; MacDonald M; Barrios M; Chu X; Islam N; Gao Y; Wong MM; Couban R; Garcia E; Chapman E; Oykhman P; Chen L; Winders T; Asiniwasis RN; Boguniewicz M; De Benedetto A; Ellison K; Frazier WT; Greenhawt M; Huynh J; Kim E; LeBovidge J; Lind ML; Lio P; Martin SA; O'Brien M; Ong PY; Silverberg JI; Spergel J; Wang J; Wheeler KE; Schneider L; Chu DK
    J Allergy Clin Immunol; 2023 Jan; 151(1):147-158. PubMed ID: 36191689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Subcutaneous and Sublingual Immunotherapy for House Dust Mite Allergy: A Network Meta-Analysis-Based Comparison.
    Kim JY; Jang MJ; Kim DY; Park SW; Han DH
    J Allergy Clin Immunol Pract; 2021 Dec; 9(12):4450-4458.e6. PubMed ID: 34464748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy and safety of dust mite subcutaneous immunotherapy in children with allergic asthma： a prospective randomized controlled study].
    Wang YN; Lu SQ; Chen H; Li YQ; Lu HY; Zhu H; Chang M
    Zhongguo Dang Dai Er Ke Za Zhi; 2024 Jun; 26(6):559-566. PubMed ID: 38926371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases.
    Yang Y; Ma D; Huang N; Li W; Jiang Q; Wang Y; Wang X; Yang L; Zhu R
    Ital J Pediatr; 2021 Apr; 47(1):101. PubMed ID: 33892756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.